RADAR24emerging & medical tracks
Frontier, not storefront
Interesting does not
mean ready.
The Radar follows early nutrients, geroscience medicines and peptides. Medical and research-use entries never render price, cart controls or human-use instructions.
NMN
Nicotinamide mononucleotideA raw material the body can use to make NAD+, a molecule involved in cellular energy. It can change biomarkers, but lasting benefits remain uncertain.
Urolithin A
UAA gut-derived molecule studied around mitochondrial quality control. One direct formulation clearly raised measured exposure, but walking, muscle and biomarker results remain mixed or exploratory, and no human trial shows longer lifespan or validated healthspan.
Ergothioneine
L-Ergothioneine · EGTA food-derived compound transported into cells by OCTN1. Exact preparations can raise measured blood exposure, but the largest cognition trial was primary-null and no human trial shows longer lifespan or validated healthspan.
Calcium AKG
Ca-AKG · Alpha-ketoglutarateA form of a molecule used in the cell's energy cycle. Longevity interest is high, but strong controlled human outcome data are still limited.
Spermidine
PolyamineA natural polyamine involved in cellular-maintenance pathways. Dietary associations are interesting, but the largest cognition trial was null and no completed supplement trial shows longer lifespan or validated healthspan.
Nicotinamide Riboside
NRA vitamin B3-related ingredient that can raise NAD-related markers. Biomarker changes are clearer than meaningful real-world benefits so far.
PQQ
Pyrroloquinoline quinoneA redox-active nutrient-like compound studied around mitochondrial signalling. Human studies are few and mostly measure indirect outcomes.
Fisetin
FlavonolA plant flavonoid studied for its possible effects on ageing cells. Most evidence is still laboratory or animal research, with human trials ongoing.
Sulforaphane
Broccoli sprout isothiocyanateA broccoli-derived compound studied in cellular-defence signalling. Formulation and conversion strongly affect measured exposure, but exposure is not efficacy and no human trial shows longer lifespan or validated healthspan.
Metformin
Biguanide medicineA medicine that lowers liver glucose output and changes cellular energy signalling. Its established role is metabolic care, not general anti-ageing use.
Rapamycin
SirolimusA medicine that turns down the mTOR growth pathway. Animal longevity results are striking, but human ageing evidence and safety trade-offs remain unresolved.
Acarbose
Alpha-glucosidase inhibitorSlows the digestion of carbohydrates and reduces post-meal glucose spikes. Its medical use does not automatically translate into a longevity effect.
Canagliflozin
SGLT2 inhibitorHelps the kidneys remove glucose from the blood. It has important medical uses, but healthy-ageing use has not been established.
17α-Estradiol
17-alpha estradiolA form of estradiol studied mainly in animals for sex-specific metabolic and ageing effects. Human longevity relevance is not yet known.
BPC-157
Body protection compound 157An experimental peptide explored mainly in animal injury and tissue-repair models. Reliable controlled human outcome data are not yet available.
TB-500
Thymosin beta-4 fragmentA research peptide related to thymosin biology and tissue repair. Consumer recovery and longevity benefits have not been established in controlled human studies.
MOTS-c
Mitochondrial-derived peptideA peptide made from mitochondrial genetic material and studied in metabolic adaptation. Human treatment evidence remains at an early stage.
Epitalon
EpithalonA small synthetic peptide promoted around sleep, pineal and telomere theories. Modern independent human research remains limited.
Retatrutide
Triple incretin agonistA triple-receptor medicine candidate being studied for metabolic disease and weight management. It remains a controlled clinical research programme.
CJC-1295
Growth-hormone-releasing hormone analogueAn experimental peptide designed to extend growth-hormone-releasing signals. Reliable healthy-ageing or recovery benefits have not been demonstrated.
Ipamorelin
Growth-hormone secretagogueAn experimental peptide that stimulates growth-hormone signalling through the ghrelin receptor. Long-term benefits and risks remain uncertain.
GHK-Cu
Copper peptideA copper-binding peptide studied in skin, wound and connective-tissue biology. Topical interest does not prove a whole-body longevity effect.
Semaglutide
GLP-1 receptor agonist · WegovyA GLP-1 medicine used in selected metabolic care. Its substantial human evidence relates to specific medical outcomes, not a universal longevity effect.
Dasatinib + Quercetin
D+Q senolytic protocolA medicine-plus-flavonoid combination studied for removing certain ageing cells. Human research is small and the medical risks are significant.